Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 19 (PEX19) is a cytosolic farnesylated protein required for the assembly, maintenance, and inheritance of peroxisomes in eukaryotic cells[3][4][1]. PEX19 functions primarily as a chaperone and import receptor for peroxisomal membrane proteins (PMPs), recognizing and binding newly synthesized PMPs in the cytosol, preventing their aggregation, and escorting them to the peroxisomal membrane via interaction with another factor, PEX3[1][2][4][5]. PEX19 is also directly involved in targeting and inserting PMPs into the peroxisomal membrane and plays roles in the division and inheritance of peroxisomes, particularly by interacting with PEX3 and PEX25 in yeast, or analogous pathways in mammals[1]. Mutations in the PEX19 gene can cause severe peroxisome biogenesis disorders (PBDs), notably Zellweger syndrome spectrum, a group of congenital disorders marked by multi-organ dysfunction, especially affecting the brain, liver, and skeletal system, typically resulting in early lethality[6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 19 (PEX19).